Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TERN-601 by Terns Pharmaceuticals for Obesity: Likelihood of Approval
TERN-601 is under clinical development by Terns Pharmaceuticals and currently in Phase I for Obesity. According to GlobalData, Phase I...